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Purpose/Objective: Respiratory-gated treatments have 
achieved solid foothold in left-sided breast cancer 
radiotherapy. Typically the treatments require several 
breath-holds that can be time-consuming and difficult for 
some patients. The aim of this study was to investigate the 
reduction of beam-on time in left-sided breast volumetric 
modulated arc therapy (VMAT) and tangential step-and-shoot 
IMRT (SSIMRT) treatments when flattening filter free (FFF) 
beams were used instead of flattened beams. In addition, 
dosimetric plan parameters for PTV and a set of OARs were 
determined to evaluate plan equivalence. 
Materials and Methods: Six women with left-sided breast 
cancer with a mean PTV volume of 1118±100cm3 were 
enrolled in this retrospective study. Four different treatment 
plans were generated for each patient based on breath-hold 
CT: VMAT with two tangential dual arcs of 45-50 degrees 
using flattened (VMAT) and FFF beams (VMAT FFF) as well as 
SSIMRT with two static tangential fields using flattened 
(SSIMRT) and FFF beams (SSIMRT FFF) (Figure 1). Plans were 
generated for Elekta Infinity with Agility leaves and 6MV 
photons using Monte Carlo dose calculation (Monaco 
v3.30.01, Elekta AB). The prescribed dose (40.05 Gy/15 fr) 
was normalised to the mean dose of PTV excluding the build-
up area of 5 mm from the body surface. The dosimetric 
parameters evaluated were 95% dose coverage of PTV (D95%) 
and dose to the hottest 1cm3 (Dmax). Moreover, ipsilateral 
lung (V20Gy and Lung Dmean), heart (Heart Dmean) and 
contralateral breast (BreastDEX Dmean) doses were included 
in the plan evaluation. The plans were irradiated with Elekta 
Infinity linear accelerator. Statistical significance was 
evaluated by t-test. 
 
 
Figure 1. Axial dose distributions of a VMAT FFF (A) and an 
SSIMRT FFF (B) treatment plan for one patient in the study. 
 
Results: A significant (p<0.01) reduction of 27% and 25% was 
observed in beam-on time when FFF beams were utilized 
instead of flattened beams in VMAT and SSIMRT, even though 
on average 201 and 72 additional MUs were delivered with 
FFF plans, respectively. In general, VMAT plans provided 
higher dose coverage, lower dose maximum in PTV and lower 
OAR doses than SSIMRT (Table 1). Only the contralateral 
breast dose was slightly lower with SSIMRT plans. The use of 
FFF decreased the PTV dose coverage (D95%) (VMAT: 0.8%, 
p<0.05; SSIMRT: 2.8%, p<0.05) and increased the lung doses 
slightly. However, the avoidance of contralateral breast was 
more effective using FFF beams. The mean cardiac dose was 
similar between the FFF and flattened beams. Overall, the 
differences in OAR parameters were small and non-
significant. The only exception was Lung V20Gy in SSIMRT 
plans, where on average 10.8% higher (p<0.05) volume was 
observed with SSIMRT FFF. 
 
Table 1. Means and standard deviations of studied 
parameters. 
 
 
 
Conclusions: FFF beams enable significant reduction in 
beam-on time in VMAT and SSIMRT compared to flattened 
beams. In this study, minor effects were seen in dosimetric 
parameters between the treatment plans using flattened and 
FFF beams. In terms of dosimetric parameters VMAT is 
superior to SSIMRT. 
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Purpose/Objective: Central Lung Depth (CLD) is still utilised 
in breast radiotherapy to discern the treatment area whilst 
limiting the amount of lung receiving high doses. 
Traditionally a limit of 2cm CLD is applied in the majority of 
cases. With the implementation of CT planning and ability to 
analyse the volume of lung receiving dose we are able to 
accurately record the impact of the field setup on this 
specific region of interest. Further, with the implementation 
of Deep Inspiration Breath-hold (DiBH) for all left sided 
breast treatments, an increase in CLD is expected, however 
the overall effect on the percentage of lung receiving high 
doses should be similar or decreased. This study aims to 
verify that an increase in CLD for left breast patients treated 
in DiBH does not equate to an increase in the percentage of 
lung volume within the field. The study also aims to further 
investigate if there is any correlation between these 
measurements and to determine if traditional methods for 
limiting lung dose in breast irradiation should be updated to 
account for DiBH. 
Materials and Methods: Over 250 left breast tangential 
treatments with DiBH and Forward-Planned IMRT have been 
delivered across our centres since the implementation of the 
Dyn'R SDX breath-hold system in March 2013. A further 65 
patients were treated with DIBH, forward planned IMRT and a 
mono-isocentric breast technique with regional nodal 
irradiation. During the pre-treatment CT session two scans 
are acquired, one in DiBH and one in free-breathing (FB). The 
treatment is planned on the DiBH CT and then, based on 
tissue volume equivalence, the plan is copied to the FB scan. 
Both plans are analysed to determine the CLD, left lung V18Gy 
and the volume (cc) and percentage of lung receiving at least 
50% of the TD (V50%). 
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Results: With DiBH there is an increase in treated lung 
volume, however it equates to a mean reduction in the 
overall percentage of lung treated. Although there appears to 
be a relationship between the V50%, V18Gy and CLD, initial 
results show that traditional CLD limits may not be as 
relevant when using DiBH. 
  
 
Conclusions: Overall, DiBH enables us to meet planning 
constraints more effectively and although DiBH increases the 
CLD or volume of lung in the field for nearly all cases this 
does not equate to an increase in the percentage of total 
lung irradiated. A CLD value can be used as a guide for field 
delineation however results suggest that volumetric 
information should be reviewed in all cases, particularly if 
target coverage will be compromised.  
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Purpose/Objective: External dosimetry audits are a key 
element of clinical trial QA programmes to minimise 
systematic discrepancies in treatment delivery having a 
detrimental impact on the trial question. Audits can be 
costly, time intensive and require dedicated staff expertise. 
A study was set-up to investigate whether remote evaluation 
methods along with appropriately executed in-house QA 
programmes could provide a feasible and acceptable 
alternative to external dosimetry audit visits in the context 
of VMAT delivery. 
Materials and Methods: Eight radiotherapy centres (nine 
linacs) were included, incorporating various combinations of 
delivery equipment and treatment planning systems (TPS). 
Each centre was asked to plan a complex planning case 
previously used in the UK National Rotational Radiotherapy 
Audit [1, 2] and up to two of the current Trans-Tasman 
Radiation Oncology Group (TROG) clinical trial benchmarking 
exercises (head and neck and/or prostate bed) for 
independent verification. The external dosimetry audit was 
performed with the PTW Octavius4D phantom and seven29 2D 
array. Plans were evaluated using absolute dose global 
gamma (γ) index calculations, with a 10% threshold and 
normalised to a point in a high dose, low dose gradient 
region. Prior to the external dosimetry audit, sites were 
asked to report the results of their in-house QA on all audit 
plans and describe their analysis methods. A third aspect of 
the study evaluated a software program (Mobius [3]) as a tool 
for independently calculating dose on DICOMRT plans and 
reconstructed MLC treatment delivery logs allowing remote 
evaluation of VMAT delivery. 
Results: The external dosimetry audit yielded results for both 
2D planar and full 3D dose comparison with the TPS. A 
summary of the mean gamma pass rates for a range of 
gamma criteria is presented in Table 1. 
 
 
A review of in-house QA programmes highlighted a wide 
variation in approach. All sites indicated that their in-house 
QA of the plans met minimum local criteria, while the 
external audit did not reveal any contradictory results. This is 
in contrast with a recent study which reported institutional 
patient-specific IMRT QA did not always predict unacceptable 
results [4]. The difference may be related to the prospective 
nature of the in-house QA in our study along with the small 
number of participating centres. Gamma pass rates ranged 
from 89.5 - 100% (mean = 98.0%) and 63.1 - 99.3% (mean = 
87.2%) for 3%/3mm and 2%/2mm respectively for the plans 
calculated with Mobius, while greater variation in results 
